Article Sidebar

PDF (Tiếng Việt)
Published: 2026-04-14
Abstract Views: 0
Views PDF (Tiếng Việt): 0
DOI: https://doi.org/10.52163/yhc.v67iCD4.4817
Issue
Tập 67 Số CĐ4-HN Ký sinh trùng-HN Hóa sinh 2026
Section
Articles
How to Cite
Đức, N. V., Châu, T. M., Nam, N. T., & Thường, N. T. (2026). ISOLATION OF HERPES SIMPLEX VIRUS (HSV) FROM VESICULAR LESIONS. Vietnam Journal of Community Medicine, 67(CD4). https://doi.org/10.52163/yhc.v67iCD4.4817

ISOLATION OF HERPES SIMPLEX VIRUS (HSV) FROM VESICULAR LESIONS

Nguyen Van Duc1, Tran Minh Chau1, Nguyen Thanh Nam2, Nguyen Thi Thuong3
1 Hanoi Medical University
2 Central Dermatology Hospital
3 Central Institute of Hygiene and Epidemiology

Main Article Content

Abstract

Objective: To isolate HSV from clinical samples of vesicular lesions on Vero cells.


Methods: A cross-sectional study was conducted on vesicular lesions suspected by HSV.


Results: Twenty strains of HSV (HSV-1 and HSV-2) were isolated on African green monkey kidney cells (Vero) from 37 clinical samples of facial and genital vesicular lesions suspected by HSV (54,1%). Among these, 90% of the strains were isolated from facial herpes. The positivity rate in the group that had not used specific antiviral drugs before sample collection was higher than that had used, although this difference was not statistically significant. The positivity rates also showed no significant difference between males and females. The study obtained 12 strains from patients who had not used specific any antiviral drugs (naiive), which could be used for identification of genetic polymorphisms of HSV strains circulating in Vietnam.


Conclusion: In this study, a relatively high positivity rate (54.1%) was observed when isolating HSV on Vero cells from vesicular skin lesions. Isolated virus strains can be submitted for phenotypic testing of determination of susceptibility of HSV to antiviral drugs and evaluation of the efficacy of new antiviral drugs.

Article Details

Keywords

HSV, isolation, vesicle, Vero, ACV

References

1. Looker KJ, Johnston C, Welton NJ, James C, Vickerman P, Turner KME, et al. The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study. BMJ Glob Health. 2020;5(3):e001875.
2. de Oliveira Bonfim FF, Villar LM, Croda J, Pereira JG, Guimarães ACS, da Silva SR, et al. High silent prevalence of human herpesvirus 1 (HSV-1) infection affecting the indigenous reservation of the municipality of Dourados, Central-West Brazil. BMC Infect Dis. 2024 July 17;24(1):700.
3. Coyle PV, Desai A, Wyatt D, McCaughey C, O’Neill HJ. A comparison of virus isolation, indirect immunofluorescence and nested multiplex polymerase chain reaction for the diagnosis of primary and recurrent herpes simplex type 1 and type 2 infections. J Virol Methods. 1999 Dec;83(1–2):75–82.
4. Nag S, Sengupta M, Sarkar S, Ray Y, Chattopadhyay D, Sengupta M. Isolation, characterization and acyclovir susceptibility of herpes simplex virus isolates among immunocompromised patients. Indian J Sex Transm Dis AIDS. 2021;42(1):19–23.
5. Harfouche M, AlMukdad S, Alareeki A, Osman AMM, Gottlieb S, Rowley J, et al. Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. Sex Transm Infect. 2025 May 19;101(4):214–23.
6. Field HJ, Bell SE, Elion GB, Nash AA, Wildy P. Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother. 1979 Apr;15(4):554–61.
7. Lewis ME, Warren KG, Jeffrey VM, Tyrrell DL. Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia. Antimicrob Agents Chemother. 1983 Mar;23(3):487–9.